Seffrin is Chief Executive Officer, American Cancer Society, Atlanta, GAAmerican Cancer SocietyCa A Cancer Journal for CliniciansSeffrin JR. Health literacy in the information age: communicating cancer information to patients and families - Merriman, Ades () Citation Context ...26). ...
15 Sensitivity analyses assessed the overall risks of developing SPCs when restricting to only the first SPC (disallowing multiple events in an individual) or by starting follow-up at 1 year after the FPC diagnosis. Outcomes The primary outcomes were incidence (per 10 000 person-years) and ...
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA Donatus U. Ekwueme & Temeika L. Fairley Contributions Conceptualization: JGT, DUE, TLF, SBW; Data curation: CDB, XZ; Formal analysis: AG, JR, XZ; Funding acquisition: JGT, DUE, TLF, ...
Identification of new genetic markers may improve the prediction of colorectal cancer prognosis. Our objective was to examine genome-wide associations of germline genetic variants with disease-specific survival in an analysis of 16,964 cases of colorecta
The specific serious adverse events of deep vein thrombosis and pulmonary embolism, as well as uterine neoplasia, are discussed in the following text. FDA approval In October 1998 the FDA in the United States, on the basis of the NSABP results, approved tamoxifen for the primary prevention of ...
Meta-analyses included summary estimates based on Cox models of twelve datasets using ~10.4 million variants for 96,661 women with breast cancer and 7697 events (breast cancer-specific deaths). Oestrogen receptor (ER)-specific analyses were based on 64,171 ER-positive (4116) and 16,172 ER-neg...
Courtney R (2015) The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: PB - Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease...
Conclusions Raloxifene is as effective as tamoxifen in reducing the risk of invasive breast cancer and has a lower risk of thromboembolic events and cataracts but a nonstatistically significant higher risk of noninvasive breast cancer. The risk of other cancers, fractures, ischemic heart disease, and...
Winship Cancer Institute, Emory University, Atlanta, GA, USA Kevin Kalinsky Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA Joyce O’Shaughnessy Department of Medicine and Research, Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus, Frankfurt, Germany...
Estimation of cause-specific relative risk does not require independence of the outcome and competing events to obtain valid relative risk estimates.54 In the current study, data on exposures and some potential confounders were based on self-report and HBV/HCV status was not available for all ...